Robert J. Weikert

1.0k total citations
17 papers, 736 citations indexed

About

Robert J. Weikert is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert J. Weikert has authored 17 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert J. Weikert's work include Synthesis and Biological Evaluation (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Retinal Diseases and Treatments (3 papers). Robert J. Weikert is often cited by papers focused on Synthesis and Biological Evaluation (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Retinal Diseases and Treatments (3 papers). Robert J. Weikert collaborates with scholars based in United States, Switzerland and Mexico. Robert J. Weikert's co-authors include David T. Connor, Paul C. Unangst, David G. Loughhead, Sunil Patel, Piotr Szczęsny, Everson Nogoceke, Dietmar Schwab, Shamil Sadikhov, Pravin U. Dugel and Sascha Fauser and has published in prestigious journals such as Journal of Medicinal Chemistry, Ophthalmology and The Journal of Organic Chemistry.

In The Last Decade

Robert J. Weikert

17 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Weikert United States 13 293 247 230 188 50 17 736
Ian L. Scott United States 14 396 1.4× 254 1.0× 49 0.2× 49 0.3× 52 1.0× 23 762
Tom R. Dean United States 7 142 0.5× 236 1.0× 138 0.6× 24 0.1× 37 0.7× 7 409
Cathie Xiang United States 13 44 0.2× 184 0.7× 120 0.5× 68 0.4× 118 2.4× 17 572
Peter G. Klimko United States 12 136 0.5× 125 0.5× 118 0.5× 19 0.1× 37 0.7× 17 426
Bryant A. Gilbert United States 14 147 0.5× 487 2.0× 64 0.3× 20 0.1× 56 1.1× 24 628
Teruo Oku Japan 17 493 1.7× 339 1.4× 7 0.0× 25 0.1× 91 1.8× 28 911
Whei‐Mei Wu United States 13 41 0.1× 148 0.6× 86 0.4× 25 0.1× 41 0.8× 20 398
Dominique Swinnen Belgium 13 285 1.0× 476 1.9× 13 0.1× 8 0.0× 59 1.2× 18 691
Jennifer Pocas United States 13 188 0.6× 309 1.3× 33 0.1× 12 0.1× 24 0.5× 15 458
E. Hampton Sessions United States 16 240 0.8× 295 1.2× 13 0.1× 8 0.0× 117 2.3× 20 635

Countries citing papers authored by Robert J. Weikert

Since Specialization
Citations

This map shows the geographic impact of Robert J. Weikert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Weikert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Weikert more than expected).

Fields of papers citing papers by Robert J. Weikert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Weikert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Weikert. The network helps show where Robert J. Weikert may publish in the future.

Co-authorship network of co-authors of Robert J. Weikert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Weikert. A scholar is included among the top collaborators of Robert J. Weikert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Weikert. Robert J. Weikert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sahni, Jayashree, Pravin U. Dugel, Sunil Patel, et al.. (2020). Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology. 138(9). 955–955. 92 indexed citations
2.
Sahni, Jayashree, Sunil Patel, Pravin U. Dugel, et al.. (2019). Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema. Ophthalmology. 126(8). 1155–1170. 179 indexed citations
3.
Patel, Sunil, Jayashree Sahni, Shamil Sadikhov, et al.. (2018). Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial. Investigative Ophthalmology & Visual Science. 59(9). 1959–1959. 1 indexed citations
4.
Delporte, Marie‐Laure, Scott Schobel, Lothar Lindemann, et al.. (2017). Results and evaluation of a first‐in‐human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods. British Journal of Clinical Pharmacology. 84(3). 445–455. 7 indexed citations
5.
Lucas, Matthew C., Robert J. Weikert, David S. Carter, et al.. (2010). Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. Bioorganic & Medicinal Chemistry Letters. 20(18). 5559–5566. 15 indexed citations
6.
Carter, David S., Haiying Cai, Eun Kyung Lee, et al.. (2010). 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 20(13). 3941–3945. 25 indexed citations
7.
8.
Lucas, Matthew C., David S. Carter, Haiying Cai, et al.. (2009). Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4630–4633. 4 indexed citations
9.
Loughhead, David G., Lee A. Flippin, & Robert J. Weikert. (1999). Synthesis of Mexiletine Stereoisomers and Related Compounds via SNAr Nucleophilic Substitution of a Cr(CO)3-Complexed Aromatic Fluoride. The Journal of Organic Chemistry. 64(9). 3373–3375. 28 indexed citations
10.
Talamás, Francisco X., et al.. (1997). The Florisil® catalyzed [1,3]-sigmatropic shift of allyl phenyl ethers — An entryway into novel mycophenolic acid analogues. Tetrahedron Letters. 38(27). 4725–4728. 24 indexed citations
11.
Nelson, Peter H., Bruce H. Devens, Elsie M. Eugui, et al.. (1996). Structure−Activity Relationships for Inhibition of Inosine Monophosphate Dehydrogenase by Nuclear Variants of Mycophenolic Acid. Journal of Medicinal Chemistry. 39(21). 4181–4196. 41 indexed citations
12.
Smith, Bruce D., David G. Loughhead, Robert J. Weikert, et al.. (1996). Asymmetric Synthesis and Stereochemical Assignment of RS-97613, a Potent Immunosuppressive and Antiinflammatory Agent. The Journal of Organic Chemistry. 61(6). 2236–2241. 24 indexed citations
13.
Connor, David T., Wiaczeslaw A. Cetenko, Michael D. Mullican, et al.. (1992). Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents. Journal of Medicinal Chemistry. 35(5). 958–965. 67 indexed citations
14.
Weikert, Robert J., Sharon Bingham, M.A. Emanuel, et al.. (1991). Synthesis and anthelmintic activity of 3'-benzoylurea derivatives of 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole. Journal of Medicinal Chemistry. 34(5). 1630–1633. 40 indexed citations
15.
Weikert, Robert J., M.A. Emanuel, E B Fraser-Smith, et al.. (1991). ChemInform Abstract: Synthesis and Anthelmintic Activity of 3′‐Benzoylurea Derivatives of 6‐ Phenyl‐2,3,5,6‐tetrahydroimidazo(2,1‐b)thiazole.. ChemInform. 22(45). 2 indexed citations
16.
Unangst, Paul C., David T. Connor, Robert J. Weikert, et al.. (1989). Novel indolecarboxamidotetrazoles as potential antiallergy agents. Journal of Medicinal Chemistry. 32(6). 1360–1366. 108 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian L. Scott Breakdown of academic impact, for papers by Tom R. Dean Breakdown of academic impact, for papers by Cathie Xiang Breakdown of academic impact, for papers by Peter G. Klimko Breakdown of academic impact, for papers by Bryant A. Gilbert Breakdown of academic impact, for papers by Teruo Oku Breakdown of academic impact, for papers by Whei‐Mei Wu Breakdown of academic impact, for papers by Dominique Swinnen Breakdown of academic impact, for papers by Jennifer Pocas Breakdown of academic impact, for papers by E. Hampton Sessions
Rankless by CCL
2026